abstract |
The present invention discloses highly active, highly selective BTK kinase inhibitor compounds and their use in the preparation of medicaments for treating diseases associated with BTK targets. Specifically disclosed are compounds of formula (I), isomers thereof and pharmaceutically acceptable salts thereof. [Chemical 1] |